本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Immatics N.V.

10.00
+0.14001.42%
盤後10.000.00000.00%18:00 EDT
成交量:49.37萬
成交額:496.09萬
市值:13.41億
市盈率:-5.29
高:10.26
開:9.70
低:9.70
收:9.86
52周最高:12.41
52周最低:3.30
股本:1.34億
流通股本:6,252.40萬
量比:1.41
換手率:0.79%
股息:- -
股息率:- -
每股收益(TTM):-1.8903
每股收益(LYR):-1.8903
淨資產收益率:-37.10%
總資產收益率:-18.08%
市淨率:2.38
市盈率(LYR):-5.29

資料載入中...

公司資料

公司名字:
Immatics N.V.
交易所:
NASDAQ
成立時間:
- -
員工人數:
645
公司地址:
Paul-Ehrlich-Strasse 15,Tübingen,Baden-Württemberg,Germany
郵編:
72076
傳真:
49 7071 5397 900
簡介:
Immatics N.V.於2020年3月10日成立,是一家荷蘭私人有限責任公司。該公司是一家專註於開發基於T細胞受體的免疫療法的生物製藥公司。

董事

名稱
職位
Harpreet Singh
Chief Executive Officer and Executive Director
Adam Stone
Non-Executive Director
Alise Reicin
Non-Executive Director
Eliot Forster
Non-Executive Director
Heather L. Mason
Non-Executive Director
Mathias Hothum
Non-Executive Director
Michael G. Atieh
Non-Executive Director
Paul R. Carter
Non-Executive Director
Peter Chambré
Non-Executive Director and Chair

股東

名稱
職位
Harpreet Singh
Chief Executive Officer and Executive Director
Venkat Ramanan
Chief Financial Officer
Amie Krause
Chief People Officer
Carsten Reinhardt
Chief Development Officer
Cedrik Britten
Chief Medical Officer
Edward Sturchio
General Counsel
Jordan Silverstein
Head of Strategy
Rainer Kramer
Chief Business Officer
Steffen Walter
Chief Operations Officer
Toni Weinschenk
Chief Innovation Officer